Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

2.14
Delayed Data
As of 3:15pm ET
 +0.03 / +1.42%
Today’s Change
1.52
Today|||52-Week Range
8.12
-63.67%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close2.11
Today’s open2.10
Day’s range2.05 - 2.15
Volume173,335
Average volume (3 months)1,093,016
Market cap$85.7M
Dividend yield--
Data as of 3:15pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-91.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...+0.24+8.22%
SNSSSunesis Pharmaceutic...+0.01+0.87%
CTRVContraVir Pharmaceut...-0.05-1.33%
OGENOragenics Inc-0.01-0.66%
Data as of 3:26pm ET, 09/02/2015

Financials

Last reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$24.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Chief Operating &
Medical Officer
Dragan Cicic
Corporate headquarters
New York, New York

Forecasts

Partner Offers